Come up with a name for your new list and we'll add to it:
Memory Pharmaceuticals raised a round of funding on , . Investors include
New England Partners.
Memory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bip…